Introduction {#S0001}
============

According to the International Diabetes Federation,[@CIT0001] some 425 million people worldwide, or 8.8% of the adults aged 20--79 years are estimated to have diabetes. If these trends continue, 629 million people aged 20--79 years will have diabetes by 2045. In high-income countries, approximately 87--91% of all people with diabetes are estimated to have type 2 diabetes, 7--12% to have type 1 diabetes, and 1--3% to have other types of diabetes. Globally, diabetes results in USD 727 billion being spent yearly by people with diabetes only on healthcare, which corresponds to one of every eight dollars spent on healthcare. Approximately 4.0 (3.2--5.0) million people aged between 20 and 79 years are estimated to die from diabetes in 2017, which is equivalent to one death every 8 seconds. Diabetes accounted for 10.7% of the global all-cause mortality among people in this age group. To date, about 150--200 million people require insulin therapy worldwide,[@CIT0002] and according to recent research by Stanford University,[@CIT0003] insulin use is estimated to increase from 516.1 million 1000 IU vials per year in 2018 to 633.7 million per year in 2030. Insulin is available in rapid-, short-, intermediate-, and long-acting types that may be injected separately or mixed in the same syringe. Conventional insulin administration involves subcutaneous injection with syringes marked in insulin units. When insulin was first discovered in the early 1920s, the method of delivery used large glass syringes and reusable needles, both of which needed sterilization by boiling after each use. For over 50 years, vial and syringe remained the only delivery option available for routine clinical use. The first manufactured insulin pen was introduced in 1985,[@CIT0004] and today several pen-like devices and insulin-containing cartridges are available that deliver insulin subcutaneously through a needle. The original needles for subcutaneous injections were of a much larger diameter (25G) and longer than today's, with a high risk of intramuscular insulin delivery.[@CIT0005] Furthermore, although hypodermic needles are effective, the pain, anxiety, needle phobia, and difficulty of use have made them widely unpopular with patients. Consequently, there is poor compliance in initiating and adhering to needle-dependent therapies such as insulin administration.[@CIT0008] Manufacturers responded by introducing thinner, shorter, and more accurate pen needles, leading to a reduction in necessary injection force, skin trauma, and pain.[@CIT0006] In many patients (e.g., especially those who are neurologically impaired and those using multiple daily injection regimens), these devices have been demonstrated to improve the accuracy of insulin administration and/or adherence.[@CIT0007] In addition, more diabetes medications have been recently made available for injection: for example, GLP-1 receptor agonists when given by subcutaneous injection with pen devices, become receptor bound and act similarly to the native hormone. Therefore, there is a medical need to develop less painful needles and more convenient delivery systems. With this purpose, Pikdare has been developing three-bevel needles with improved technical characteristics, namely the primary bevel angle being lower (7.5° vs 11°) than common bevels: this makes the needle tip longer and with a more streamlined shape, thus allowing for a more gradual insertion into skin ([Figure 1](#F0001){ref-type="fig"}). The aim of this study was to investigate in a standardized laboratory setting the penetration force and sliding force of different 31/32/33/34 gauge pen needles available in 3.5/4/5/8 mm length and 3/5 bevel tips for subcutaneous injection through pen needles and injection pens.Figure 1Tested needles: (**A**) Pikdare three bevels needle, with a lower primary bevel angle (7.5°) and a more streamlined shape (**B**) traditional three bevels needle, with a higher primary bevel angle (11°).

Methods {#S0002}
=======

Test methodology was based on ISO 7864:2016, annex D. The needle to be tested was inserted into a polyurethane substrate at a specific constant speed and the force for insertion was recorded as a function of penetration depth. A load cell was utilized to measure force during different stages of insertion.

Maximum force was measured by using an Instron universal testing machine (Instron, Norwood, MA), equipped with a 100 N load cell. As a human skin substitute, we used a PU foil with 0.4±0.04 mm thickness and 85°±10 Shore A hardness (MELAB Medizintechnik und Labor GmbH - DE - 71229 Leonberg -- Germany). A substrate holder with a circular open penetration area having a nominal diameter of 10 mm was used.

G31 and G32 needles from major manufacturers were selected for this study since they represent the "gold standard" size for insulin administration. Furthermore, G33 and G34 needles were also tested in the study since they represent a more innovative option available on the market. Products tested included a selection of PiC needles (Pikdare S.p.A.) and needles produced by another manufacturer (1 batch per each product, 20 samples per each batch): when the sample size in each of the eight groups is 20, a 0.05 level two-sided *t*-test for independent samples of the specified contrast in a one-way analysis of variance will have 80% power to detect a Contrast Effect size, Δ=\|C\|/(σ) of 0.64. PiC G 32×4 pen needleG 32×4 3-bevel pen needleG 32×4 5-bevel pen needlePiC G 33×4 pen needlePiC G 34×3.5 pen needlePiC G 31×8 pen needleG 31×5 3-bevel pen needleG 31×5 5-bevel pen needle

The PU foil was pierced by the pen needle cannula using the testing machine with a constant speed of 100 mm/min. The cannula penetration depth into the foil was 8/10 of the cannula length at the patient end. The cannula was inserted into the foil at a 90° angle. Two values were recorded for each needle tested: Peak penetration force -- the maximum force required to insert the needle into the substrate. This force corresponds to the maximum force value in the force profile (in grams).Sliding force -- the average "friction" force calculated using up to 80% of the penetration depth the sliding load (in grams), measured as the average of the whole drag force.

An example of a typical force profile is shown in [Figure 2](#F0002){ref-type="fig"}.Figure 2Typical force profile during the penetration of the test foil with a needle, showing the maximum load peak, e.g., the maximum force from the cutting resistance, followed by the sliding of the cannula.

Data were analyzed descriptively (mean, standard deviation, 95% confidence interval, median, min and max values) and graphically with boxplots. In boxplots, the median is identified by a line inside the box; the length of the box is the interquartile range (IQR) computed from Tukey's hinges; values more than three IQRs from the end of a box are labeled as extreme, denoted with an asterisk (\*); values more than 1.5 IQRs but less than 3 IQRs from the end of the box are labeled as outliers (o).

Moreover, univariate analysis of variance was applied, estimated marginal means were calculated and Bonferroni adjusted multiple comparisons were made limiting type I errors due to alpha inflation. The statistical software used was IBM SPSS Statistics Version 23.

Results {#S0003}
=======

Descriptive statistics of max load and average sliding relative to the eight pen needles are presented in [Table 1](#T0001){ref-type="table"} (n, mean and standard deviation) and in [Figures 3](#F0003){ref-type="fig"} and [4](#F0004){ref-type="fig"}.Table 1Descriptive statistics of maximum load and average sliding by pen needlePen needleStatisticMax load (gf)G32×4 PiCMean53.990Std. deviation4.2776G32×4 3-bevelMean58.660Std. deviation7.1142G32×4 5-bevelMean73.425Std. deviation7.6463G33×4 PiCMean37.880Std. deviation2.1598G34×3.5 PiCMean36.505Std. deviation2.8489G31×8 PiCMean52.830Std. deviation5.9772G31×5 3-bevelMean65.260Std. deviation3.2464G31×5 5-bevelMean74.640Std. deviation3.6222Average sliding (gf)G32×4 PiCMean4.590Std. deviation0.5291G32×4 3-bevelMean4.455Std. deviation1.6240G32×4 5-bevelMean4.210Std. deviation1.5186G33×4 PiCMean4.955Std. deviation1.1901G34×3.5 PiCMean4.255Std. deviation0.9757G31×8 PiCMean4.110Std. deviation0.5937G31×5 3-bevelMean4.890Std. deviation1.4668G31×5 5-bevelMean3.010Std. deviation1.0848[^1] Figure 3Maximum load by pen needle.**Abbreviation:** gf, gram-force.Figure 4Average sliding by pen needle.**Abbreviation:** gf, gram-force.

Based on maximum load results, as shown in [Table 2](#T0002){ref-type="table"}, PIC G32×4 pen needles were compared to other G32×4 needles. In the first comparison, the maximum load of the PiC G32×4 was lower than with the G32×4 3-bevel needle (Δ=4.670), but statistical significance was not reached (*p*=0.064). In the second comparison, the maximum load of the PiC G32×4 was significantly lower than with the G32×4 5-bevel needle (Δ=19.435, *p*\<0.0001). The comparison of G33×4 PiC and G34×3.5 PiC needles with G32 needles demonstrated a lower maximum load with G33 and G34, reaching statistically significant differences (*p*\<0.0001).Table 2Pairwise comparison of maximum load of different pen needles evaluated in the studyDependent variable(I) Pen needle(J) Pen needleMean difference (I−J)*p*-value95% Confidence interval for difference^a^Lower boundUpper boundMax load (gf)G32×4 PiCG32×4 3-bevel−4.6700.064−9.4820.142G32×4 5-bevel−19.435\*0.000−24.247−14.623G33×4 PiCG32×4 PiC−16.110\*0.000−20.922−11.298G32×4 3-bevel−20.780\*0.000−25.592−15.968G32×4 5-bevel−35.545\*0.000−40.357−30.733G34×3.5 PiCG32×4 PiC−17.485\*0.000−22.297−12.673G32×4 3-bevel−22.155\*0.000−26.967−17.343G32×4 5-bevel−36.920\*0.000−41.732−32.108[^2]

Average sliding results were also compared for G32, G33, and G34 pen needles without showing statistically significant differences, therefore with comparable sliding performances among tested needles ([Table 3](#T0003){ref-type="table"}).Table 3Pairwise comparison of average sliding of different pen needles evaluated in the studyDependent variable(I) Pen needle(J) Pen needleMean difference (I−J)*p*-value95% Confidence interval for difference^a^Average sliding (gf)G32×4 PiCG32×4 3-bevel0.1351.000−0.9851.255G32×4 5-bevel0.3801.000−0.7401.500G33×4 PiC−0.3651.000−1.4850.755G34×3.5 PiC0.3351.000−0.7851.455[^3][^4]

Univariate analysis of variance with multiple comparisons has been done also on log-transformed data to satisfy the homoskedasticity and normality of distribution, showing the same results.

Discussion {#S0004}
==========

A hypodermic needle is typically formed from an elongate tube or cannula having a fluid-conducting lumen and characterized by a central axis. The proximal end of the hypodermic needle is typically configured for mating to, or is otherwise affixed to a fluid delivery device such as a hypodermic syringe. The distal end of the hypodermic needle is typically provided with a pointed tip geometry for piercing elastomeric septum and/or a patient's flesh or tissue so as to deliver the medicament held in the syringe. Various aspects merit to be addressed when designing the pointed tip of the hypodermic needle. For instance, one would like to minimize the needle penetration force necessary for urging the pointed tip of the needle through the skin and flesh structure of the patient. It is generally recognized that by reducing needle penetration force, the patient will experience less pain, making the injection more comfortable. Sliding force is also associated with discomfort and/or pain since it is directly related to the friction that the needle cannula exerts on tissue during skin insertion.

The bevel is the angled surface on a shaft of a sharpened tube to form a slanting edge at the needlepoint, facilitating an atraumatic penetration through the human skin: needle tips vary in terms of bevel design, e.g., the number and angularity of the tip facets. The needlepoint, also known as "lancet point," is the sharpest point of any medical needle.[@CIT0010]

The typical design of a needlepoint frequently presents three-bevel cuts: the primary bevel, which is the surfaced as a result of grinding the tube at a specific angle α, and the two-side bevels, which are secondary grind angle β on each side of the primary bevel to form the cutting edge and a sharp needlepoint. The bevel length is by definition the longest distance of a bevel, measured from the tip of the needle to the most proximate area of grinding behind the heel. The side bevel length is measured between the juncture of the side bevel, with the outside surface of the angled surface, and the tip of the needle.

For injection delivery devices, important features include needle diameter (gauge), needle length, needle smoothness, and lubrication. Additionally, the sharpness or bluntness of a needle directly affects pain.[@CIT0009] To mitigate pain from hypodermic injections, the effect of needle geometry on pain has been investigated in several studies. Needle gauge and the mechanics of needle insertion have been shown to significantly affect pain.[@CIT0011],[@CIT0012] The force of hypodermic needle insertion has been found to positively correlate with the frequency of pain.[@CIT0008]

The results of this study demonstrated that marketed pen needles with similar technical characteristics sometimes show different performances. Remarkably, the PiC G32×4 pen needle demonstrated a significantly lower maximum load in comparison with the G32×4 5-bevel pen needle. The comparison of the G33×4 PiC and G34×3.5 PiC needles with the G32 needles demonstrated a significantly lower maximum load with G33 and G34. On the other hand, comparable sliding performances were demonstrated among tested needles.

These data are important for increasing patient and provider awareness of currently available devices for insulin administration.

The main limitation of this study is the laboratory testing of pen needles, which only allows to predict potential benefits for patients.

Conclusion {#S0005}
==========

Newer pen needles represent a significant improvement in insulin delivery, reducing the amount of force required to penetrate tissues. The force of hypodermic needle insertion has been found to positively correlate with the frequency of pain.[@CIT0008] Thus, needle tip sharpness and other factors, such as lubrication, which can reduce the force of insertion, are important parameters that can be optimized to increase patient acceptance.
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[^1]: **Abbreviation:** gf, gram-force.

[^2]: **Notes:** Based on estimated marginal means. \*The mean difference is significant at the 0.05 level. ^a^Adjustment for multiple comparisons: Bonferroni.

    **Abbreviation:** gf, gram-force.

[^3]: **Notes:** Based on estimated marginal means. ^a^Adjustment for multiple comparisons: Bonferroni.

[^4]: **Abbreviation:** gf, gram-force.
